NR
LLY icon

Newfound Research’s Eli Lilly LLY Stock Holding History

Newfound Research’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-207
Closed -$67K – 136
2022
Q2 		$67K Sell
207
-69
-25% -$20.7K 0.14% 101
2022
Q1 		$79K Buy
+276
New +$71K 0.1% 117
2021
Q1 		– Sell
-271
Closed -$46K – 143
2020
Q4 		$46K Buy
+271
New +$40.5K 0.12% 114

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Newfound Research's LLY Position: Q3 2022 in Review

Newfound Research sold out of Eli Lilly (LLY) in Q3 2022, closing a stake of 207 shares — an estimated $67K sold.

Newfound Research first reported a position in LLY in Q4 2020 and held it in 3 quarters. The position peaked at $79K in Q1 2022. 2,485 funds tracked by Wall St. Rank hold LLY as of Q3 2022.

  • Newfound Research reported no remaining Eli Lilly position as of Q3 2022 after selling out during the quarter.
  • Newfound Research sold 207 Eli Lilly shares in Q3 2022, an estimated $67K.
  • Newfound Research first reported a position in Eli Lilly in Q4 2020 and held it in 3 quarters.
  • Newfound Research's Eli Lilly position peaked at $79K in Q1 2022.
  • 2,485 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2022.

Based on Newfound Research's 13F filing for Q3 2022, filed 13 Oct 2022.